๐๐จ๐ง’๐ญ ๐ฆ๐ข๐ฌ๐ฌ ๐ญ๐ก๐ ๐ข๐ง๐ฏ๐ข๐ญ๐๐ญ๐ข๐จ๐ง to our panel discussion ๐ง๐๐ฑ๐ญ ๐๐ก๐ฎ๐ซ๐ฌ๐๐๐ฒ ๐๐/๐๐ on โ๐๐ก๐ ๐
๐ฎ๐ญ๐ฎ๐ซ๐ ๐จ๐ ๐๐๐ง๐๐๐ซ ๐๐๐ฌ๐๐๐ซ๐๐ก & ๐๐ซ๐๐๐ญ๐ฆ๐๐ง๐ญ ๐ข๐ง ๐๐ฎ๐ซ๐จ๐ฉ๐โ!
๐ฅ As part of the Melomanes final conference, we look forward to engaging in inspiring discussions with experts from #research, #healthcare, #civil society and #European policy to explore the challenges and opportunities shaping the future of cancer research and treatment.
๐๏ธ ๐ฃ๐ฎ๐ป๐ฒ๐น ๐ฑ๐ถ๐๐ฐ๐๐๐๐ถ๐ผ๐ป
โThe Future of #Cancer Research & Treatment in Europeโ
๐
Thursday, 17 September 2026
๐ 14:30โ16:00
๐ Collรจge Doctoral Europรฉen, Strasbourg, (46 Bd de la Victoire, 67000)
The discussion will explore how Europe can strengthen cancer research and treatment by bridging science, policy and innovation, while addressing the needs of patients and society.
๐ฅ Our panel will bring together:
๐น Ali Ammar, MD, EMBA Ammar โ Healthcare Innovation Advisor & Visiting Lecturer, Universitรฉ Catholique de Lille
๐น Merel Hennink โ General Member Board, Lung Cancer Europe
๐น Prof. Patrick Dufour โ Vice-President, Ligue contre le cancer du Bas-Rhin
๐น Dr Wolfgang Fecke โ Executive Director, European Cancer Leagues (ECL)
๐ค The discussion will be moderated by Dr. Farouk Allouche, Johanne Desbief & Ayush Shukla.
This round table will be an opportunity to bring together different perspectives and foster dialogue on how research, innovation, healthcare systems and public policy can work together to shape the future of cancer care in Europe.
๐ก ๐ Don’t miss the chance to participate by registering (for free)! https://lnkd.in/eec29Xqh
Funded by the European Union under the grant agreement 101073025. Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or the European Research Executive Agency. Neither the European Union nor the granting authority can be held responsible for them.